Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:50:22 +0200Mon, 17 Jun 2024 15:39:00 +0200Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 24, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/invokanaHuman medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 24, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/invokanaMon, 17 Jun 2024 15:39:00 +0200Human medicineInvokana-H-C-2649-PSUSA-00010077-201411: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500194439_en.pdfInvokana-H-C-2649-PSUSA-00010077-201411: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500194439_en.pdfMon, 28 Sep 2015 02:00:00 +0200Human medicine